Part: 12         Session: 145678910111213141516171819202122         Page 931932933934935936937938939940941942943944945946947948949950951952953954955956957958959960961962963964965966967968969970971972973974975976977978979980981982983984985986987988989990991992993994995996997998999 of 999

be successful for long.

Now, there's a report from England in Lancet, which I'm going to try to get and send you a copy of, that interferon, used on people that have no cold and on a group of people that have symptoms of a cold, and they have given it to people who have the symptoms and the people who have recovered promptly from the cold -- they've avoided the cold -- and people with the cold have just gone on with the cold. So it may be a nasal spray and be sold over the counter eventually. So it looks like something might happen with the common cold.

What form of interferon would this be, immune?

I don't know whether it's leukocyte or immune. I think it's leukocyte because the trial was done in '72 by Dr. Merigan of Stanford University, who went to England with a group of English who were interested in it. They showed it was a success, and they showed its success again this spring. Now, this is a story in Lancet. You never know where these things will appear -- who's done the final trials. Do you know?

Well, Lancet is one of the most authentic of all the publications.

Yes, it's a very good medical magazine. But imagine with the common cold, to take a nasal spray and avert it?

Well, you know, I think we can exist well enough with the common cold if we can get the cancer.